Company profile
Kelyniam Global, Inc.
OTC: KLYG · Healthcare · Medical - Devices
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 44
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ workforce scale, market scale
Methodology →Revenue TTM
$3.6M
Rev growth YoY (TTM)
+20.4%
Net income (FY)
—
Employees
9
as of 2026-08-25
Market cap
$1.6M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Kelyniam Global, Inc.’s financial profile?
Kelyniam Global, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
1933 Industries Inc.——Shuttle Pharmaceuticals Holdings, Inc.——Algernon Pharmaceuticals Inc.——Stemsation International, Inc.——Somatic Systems, Inc.——North American Cannabis Holdings, Inc.——Neighbors
Hartford →Key facts
CEORoss Bjella
SectorHealthcare
IndustryMedical - Devices
HeadquartersCollinsville, CT
ExchangeOTC: KLYG
Employees9
IPO date2008-04-04
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.